Alzamend Neuro Inc.

NASDAQ: ALZN · Real-Time Price · USD
2.38
-0.05 (-2.06%)
At close: Aug 15, 2025, 3:59 PM
2.41
1.26%
After-hours: Aug 15, 2025, 07:41 PM EDT

Alzamend Neuro Cash Flow Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Apr 30, 2025 Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020
Net Income
-4.51M -4.23M -5.9M -7.39M -9.95M -12.4M -15.16M -15.37M -14.88M -15.44M -12.59M -13.08M -12.36M -9.75M -8.3M -6.05M -5.05M -5.05M -5.2M -4.79M
Depreciation & Amortization
50.74K 50.74K 50.74K 50.74K 50.74K 43.38K 36.02K 28.65K 23.07K 21.29K 15.97K 10.65K 3.55K n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
325.11K 325.11K 430.47K 667.53K 955.63K 1.37M 2.69M 3.08M 3.58M 4.35M 3.97M 4.54M 4.41M 3.45M 2.89M 2.27M 2.03M 1.87M 1.91M 1.78M
Other Working Capital
-175.04K -1.2M -238.42K 638.59K 952.4K 352.45K 2.03M 1.01M 642.05K 2.2M -160.84K 42.99K 64.64K 1.79M 1.79M 1.83M 2.57M 910.77K 1.37M 896.01K
Other Non-Cash Items
-2.25M -2.15M -570.5K 1.55M 1.41M 3.65M 2.08M 2.95M 3.96M 1.6M 1.59M 885.51K 8.77K 420.29K 433.81K 374K 454.63K 609.45K 715.58K 450.21K
Deferred Income Tax
n/a 1.3M -271.84K -129.23K n/a -3.65M -2.08M -2.95M -3.96M -1.61M -1.61M -881.53K n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-175.04K -1.2M -238.42K 638.59K 670.67K 1.91M 3.59M 2.57M 2.35M 2.83M 396.52K 600.34K 1.33M -427.96K -363.13K -319.89K -152.45K 910.77K 1.37M 896.01K
Operating Cash Flow
-6.57M -7.31M -7.91M -6.03M -8.27M -9.08M -8.85M -9.68M -8.92M -8.25M -8.23M -7.93M -6.61M -6.31M -5.33M -3.73M -2.71M -1.65M -1.21M -1.66M
Capital Expenditures
-210K 147.24K 147.24K 57.24K n/a -147.24K -147.24K -147.24K n/a -106.46K -106.46K -106.46K -106.46K n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.37M 5.37M 5.37M 10.17M 4.8M 4.8M 4.8M n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-90K -90K -90K n/a -147.24K -147.24K -147.24K -147.24K n/a -5.37M -5.37M -5.37M -5.37M 4.08K 4.08K 4.08K 105K 100.92K 100.92K 153.41K
Investing Cash Flow
-300K 57.24K 57.24K 57.24K n/a -147.24K -147.24K -147.24K n/a -106.46K -106.46K -106.46K 4.69M 4.8M 4.8M 4.8M 105K 100.92K 100.92K 153.41K
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 40K 325.1K 402.11K 402.11K 362.11K 77.01K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-87.38K -87.38K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.26M 2.78M 3.84M 2.69M 2.69M 1.17M 18.29K 200.00 200.00 3.94M 3.94M 3.94M 3.94M 1.05M 1.85M 1.95M 1.95M 895.72K 589.33K 1.39M
Financial Cash Flow
10.44M 10.47M 11.9M 5.62M 3.65M 2.13M 18.29K 200.00 200.00 3.94M 3.94M 3.94M 18.85M 18.06M 18.9M 19.28M 4.45M 1.3M 951.38K 1.47M
Net Cash Flow
3.57M 3.08M 3.89M -501.47K -4.76M -7.09M -8.98M -9.83M -8.92M -4.41M -4.39M -4.09M 12.13M 11.75M 13.57M 15.56M 1.84M -252.83K -159.76K -41K
Free Cash Flow
-6.78M -7.16M -7.77M -5.97M -8.27M -9.23M -9M -9.83M -8.92M -8.36M -8.33M -8.03M -6.72M -6.31M -5.33M -3.73M -2.71M -1.65M -1.21M -1.66M